Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Pricing Attacks Fail In Key House Races; Medicare Rx Vote Protects GOP

Executive Summary

The House leadership is unlikely to change its approach to Medicare prescription drug coverage and pharmaceutical pricing following the Republican victories in the mid-term elections Nov. 5
Advertisement

Related Content

House Committee Assignments: Little Shake-Up In The New Make-Up
Generic Drug Reform Outlook: Medicare Rx Bill May Be Best Vehicle
Senate Medicare Rx Plans: Oral Chemo, Self-Injectables May Be Fallback
Senate Medicare Rx Plans: Oral Chemo, Self-Injectables May Be Fallback
Medicare Rx Outcome In Senate Will Be Influenced By Three Key Races
Maine Senate Race Pits Generic Reformer Against “Maine Rx” Author
Medicare Rx Moves To Campaign Trail; AARP Endorses Stripped Down Bill
Rx Rebates, Gifts To Physicians Would Be Public Under Torricelli Proposal
Medicare Rx Bills Unveiled: Does Provider Reimbursement Take Precedence?
FTC To Testify On Generic Reform; Agency Report May Be “Months” Away
Advertisement
UsernamePublicRestriction

Register

PS040780

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel